Skip to main content
. 2021 Sep 22;6(18):e150453. doi: 10.1172/jci.insight.150453

Figure 2. CONSORT diagram.

Figure 2

Pancreatic cancer patients with the aforementioned tumor and treatment characteristics were extracted from the Profile-Related Evidence Determining Individual Cancer Therapy (PREDICT) database at the UCSD Center for Personalized Cancer Therapy. Nine total evaluable patients were identified with SWI/SNF alterations and who received immunotherapy. Six patients with SWI/SNF alterations who did not receive immunotherapy and 4 pancreatic cancer patients without SWI/SNF alterations who did not receive immunotherapy were used as comparator arms.